As of Apr 24
| -0.54 / -1.39%|
The 10 analysts offering 12-month price forecasts for ACADIA Pharmaceuticals Inc have a median target of 42.50, with a high estimate of 50.00 and a low estimate of 38.00. The median estimate represents a +10.79% increase from the last price of 38.36.
The current consensus among 9 polled investment analysts is to Buy stock in ACADIA Pharmaceuticals Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.